Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

155

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX14	LEVIPRAM 1000	G	Levetiracetam - 1000mg	1000mg	Tablet, film coated	1,663,805 L.L
N03AX14	ZITERA	G	Levetiracetam - 1,000mg	1,000mg	Tablet, film coated	3,225,222 L.L
N03AX14	LEPITAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
N03AX14	LEVETIRACETAM ARROW	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,639,488 L.L
N03AX14	LEVETRIMED	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
N03AX14	LEVIPRAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,285,609 L.L
N03AX14	KEPAM MS	G	Levetiracetam - 500mg/5ml	500mg/5ml	Injectable solution	9,170,015 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 500mg/100ml	500mg/100ml	Injectable solution	1,869,733 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
N03AX18	VIMPAT	B	Lacosamide - 50mg	50mg	Tablet, film coated	1,024,008 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 50mg	50mg	Tablet	614,136 L.L
N03AX18	TREPADIO	G	Lacosamide - 50mg	50mg	Tablet, film coated	606,073 L.L
N03AX18	VIMPAT	B	Lacosamide - 100mg	100mg	Tablet, film coated	7,835,296 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 100mg	100mg	Tablet	4,856,647 L.L
N03AX18	TREPADIO	G	Lacosamide - 100mg	100mg	Tablet, film coated	5,202,014 L.L
N03AX18	VIMPAT	B	Lacosamide - 150mg	150mg	Tablet, film coated	11,754,896 L.L
N03AX18	TREPADIO	G	Lacosamide - 150mg	150mg	Tablet, film coated	7,555,604 L.L
N03AX18	VIMPAT	B	Lacosamide - 200mg	200mg	Tablet, film coated	13,357,859 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 200mg	200mg	Tablet	8,284,105 L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg	200mg	Tablet, film coated	8,876,013 L.L
N03AX18	TREPADIO	G	Lacosamide - 10mg/ml	10mg/ml	Syrup	948,753 L.L
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Injectable solution	13,225,715 L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg/20ml	200mg/20ml	Injectable solution	9,569,390 L.L
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Syrup	2,111,177 L.L
N03AX22	FYCOMPA	B	Perampanel - 2mg	2mg	Tablet, film coated	1,138,235 L.L
N03AX22	FYCOMPA	B	Perampanel - 4mg	4mg	Tablet, film coated	8,751,127 L.L
N03AX22	FYCOMPA	B	Perampanel - 6mg	6mg	Tablet, film coated	8,751,127 L.L
N03AX22	FYCOMPA	B	Perampanel - 8mg	8mg	Tablet, film coated	10,180,812 L.L
N03AX22	FYCOMPA	B	Perampanel - 10mg	10mg	Tablet, film coated	12,176,386 L.L
N03AX23	BRIVIACT	B	Brivaracetam - 25mg	25mg	Tablet, film coated	9,627,931 L.L

...

155

...